Ulcerative colitis, Crohn's disease and irritable bowel syndrome patients need fecal transplant research and treatment

Journal of Crohn's and Colitis

Volumn 8, Issue 2, 2014, Pages 179-

  Brown, Amy C ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENEMA;

BLOOD SAMPLING; CLOSTRIDIUM DIFFICILE; CROHN DISEASE; DYSBIOSIS; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LETTER; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ULCER; TREATMENT OUTCOME; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; FECES; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 84892862618     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.09.011     Document Type: Letter

References (5)

1. Carbonnel F., Jantchou P., Monnet E., Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol 2009, 33(Suppl. 3).
2. Borody T.J., Paramsothy S., Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013, 15(8):337.
3. Borody T.J., Campbell J. Fecal microbiota transplantation: current status and future directions. Expert Rev Gastroenterol Hepatol 2011, 5(6):653-655.
4. Borody T.J., Warren E.F., Leis S., Surace R., Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003, 37(1):42-47.
5. McKinney M. FDA slaps regs on fecal transplants. Increased steps for C. diff treatment draw mixed reactions from providers. Mod Healthc 2013, 43(21):10.